Tumour-Infiltrating Neutrophils Counteract Anti-Vegf Therapy in Metastatic Colorectal Cancer

British Journal of Cancer - United Kingdom
doi 10.1038/s41416-018-0198-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Therapy for Metastatic Colorectal Cancer

Oncologist
Cancer ResearchMedicineOncology
2006English

Optimizing Systemic Therapy Selection in Metastatic Colorectal Cancer

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2015English

Monoclonal Antibodies Targeting the IL-17/IL-17RA Axis: An Opportunity to Improve the Efficiency of Anti-Vegf Therapy in Fighting Metastatic Colorectal Cancer?

Clinical Colorectal Cancer
OncologyGastroenterology
2018English

Tumour-Infiltrating T-Cell Subsets, Molecular Changes in Colorectal Cancer, and Prognosis: Cohort Study and Literature Review

Journal of Pathology
Forensic MedicinePathology
2010English

Immunodivergence in Metastatic Colorectal Cancer

Cancer Cell
Cancer ResearchOncologyCell Biology
2018English

Dermatologic Toxicity Occurring During Anti-Egfr Monoclonal Inhibitor Therapy in Patients With Metastatic Colorectal Cancer: A Systematic Review

Clinical Colorectal Cancer
OncologyGastroenterology
2018English

Molecular Determinants of Anti-Egfr Sensitivity and Resistance in Metastatic Colorectal Cancer

British Journal of Cancer
Cancer ResearchOncology
2010English

Biochemotherapy of Metastatic Malignant Melanoma. Predictive Value of Tumour-Infiltrating Lymphocytes

British Journal of Cancer
Cancer ResearchOncology
2001English

Impact of Primary Tumour Location on Efficacy of Bevacizumab Plus Chemotherapy in Metastatic Colorectal Cancer

British Journal of Cancer
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy